Beyond the Music: How Napa's Premier Festival Funds the Future of Mental Health

RUTHERFORD, CA – August 19, 2026 – On a sun-drenched Saturday this September, the rolling vineyards of Napa Valley will host an event unlike any other. The 32nd Annual One Mind Music Festival is not just a concert, a wine tasting, or a scientific conference—it's a sophisticated fusion of all three, meticulously designed to fuel one of the most urgent missions of our time: revolutionizing mental health care. This year, the festival will welcome alt-rock band The Fray to mark the 20th anniversary of their poignant anthem, “How to Save a Life,” a fitting soundtrack for an event that has become one of the world's most influential fundraisers for brain health research.

Beneath the surface of celebrity performances and gourmet dinners lies a powerful engine for change. The festival is the flagship fundraising vehicle for One Mind, a global nonprofit that has spent three decades bridging the chasm between scientific discovery and real-world impact. With presenting sponsors Bank of America and Bristol Myers Squibb providing major backing, the event exemplifies a new paradigm in philanthropy, where culture, science, and business converge to create tangible progress.

The Engine of Innovation: Where the Money Goes

While the festival offers an unforgettable day of entertainment, its true success is measured in the millions of dollars it raises and the groundbreaking programs that money supports. Last year's event set a record, generating over $4.1 million, which contributed to One Mind's record-breaking annual fundraising total of over $14 million. This capital is not simply absorbed into an operational budget; it is strategically deployed to accelerate solutions across the mental health ecosystem.

One of the organization's flagship initiatives is the One Mind Rising Star Awards. These $300,000 grants are awarded to promising early-career scientists, providing critical funding at a stage when securing traditional grants can be challenging. Since 2005, 54 such awards have been granted, injecting over $14 million into research exploring everything from the neurobiology of eating disorders to novel therapeutic targets for psychiatric conditions. This program acts as a crucial talent pipeline, nurturing the next generation of innovators who will redefine our understanding of the brain.

Further down the development pipeline is the One Mind Accelerator. Launched in 2023, this Silicon Valley-based program identifies and nurtures early-stage startups with the potential to transform mental healthcare. The results have been remarkable: the first 37 companies to graduate from the program have collectively raised nearly $1 billion in follow-on funding and have already impacted the lives of one million people. The Accelerator focuses on high-need areas like serious mental illness, youth mental health, and precision psychiatry, ensuring that innovation is directed where it can make the most difference.

Beyond research and startups, the funds also support One Mind at Work, a global coalition of over 150 organizations committed to improving workplace mental health. Having already impacted 4.5 million employees, the program provides employers with data-driven strategies and best practices, transforming workplaces from sources of stress into pillars of support.

From Lab to Life: The Scientific Forefront

While music may be the main draw for many attendees, the festival's scientific heart beats strongest at the morning's Science & Innovation Symposium. This is where the future of mental healthcare is unveiled. This year's keynote speakers are Dr. Ekaterina Malievskaia, Co-Founder of COMPASS Pathways, and Lars Wilde, Co-Founder and CEO of Pangea Bio—two figures at the vanguard of psychiatric treatment.

Dr. Malievskaia is a central figure in the psychedelic medicine renaissance. Her company, COMPASS Pathways, is pioneering the development of psilocybin therapy for treatment-resistant depression. Their lead candidate, COMP360, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration, and their large-scale clinical trials represent some of the most advanced research in the field. Her presentation is expected to offer the latest insights into a therapeutic model that could fundamentally change how we treat severe depression.

Representing a different frontier of innovation, Lars Wilde’s Pangea Bio is harnessing the power of artificial intelligence and computational biology to de-risk and accelerate drug discovery for brain diseases. By identifying novel therapeutic targets through machine learning, his company aims to overcome the notoriously high failure rate in neuroscience R&D. Wilde’s work exemplifies the critical role of technology in untangling the complexity of the brain and developing the precision medicines of tomorrow.

A Blueprint for Impact: Corporate Giants Rally for Mental Health

Fueling this convergence of science and celebration are corporate partners who see their role as more than just writing a check. The longstanding support from presenting sponsors Bank of America and Bristol Myers Squibb is a case study in effective corporate social responsibility.

“The One Mind Music Festival represents the best of what is possible to advance the future of brain health research,” said Chris Fabro, Global HR Executive and Global Head of Compensation & Benefits at Bank of America. “We are proud of our longstanding partnership with One Mind and our support of this annual event, which is dedicated to advancing groundbreaking research and innovative solutions that can transform mental health care and expand access for all.” The financial giant is also a lead supporter of the One Mind Accelerator, directly investing in the next wave of mental health startups.

For Bristol Myers Squibb, a global biopharmaceutical company, the partnership is a natural extension of its core mission. The company actively funds the Rising Star Awards, including a 2025 grant dedicated to discovering new targets for psychiatric disorders. “Our ongoing relationship with One Mind represents a shared commitment to investing in breakthrough science,” stated Laura Gault, Senior Vice President, Head of Neuroscience Drug Development at Bristol Myers Squibb. “Together, we are catalyzing the drug development process and helping to bring more effective medicine to people living with serious mental health conditions.”

The Human Element: Integrating Lived Experience

Perhaps the most crucial element of One Mind's strategy—and what sets it apart—is its deep, structural integration of “lived experience.” The organization was founded in 1995 by Garen and Shari Staglin after their son, Brandon, was diagnosed with schizophrenia. This personal origin story infuses the organization's work with an unwavering focus on the human impact of mental illness.

This focus is formalized through the One Mind Lived Experience Council (OMLEC), a group of professionals who have personally navigated serious mental health conditions. Far from being a token advisory board, OMLEC is actively involved in every facet of the organization’s work. Its members help select the Rising Star Award winners, ensuring research is relevant to patients. They advise the startups in the Accelerator—including Pangea Bio—helping entrepreneurs design products that truly meet user needs. This ensures that the solutions being developed are not just scientifically novel but also practical, accessible, and empathetic.

As One Mind CEO Dr. Kathy Pike explained, the festival is the ultimate expression of this integrated philosophy. “The One Mind Music Festival is a rare and memorable day where mental health and music harmonize,” she said. “This annual tradition brings together the brightest scientists, our biggest supporters, and creatives in the upper echelon of performance, wine, and culinary craft to celebrate all we have accomplished together and to plan for a future where individuals and families living with serious mental illness have real, lasting solutions.”